PRKCB and diabetic kidney disease: Moreover, the involvement of phospholipase C-γ1 (PLC-γ1) in DKD development is highlighted; PLC-γ1 inhibition curbs PKC-β-induced protein kinase B (AKT) S473 phosphorylation and prevents collagen I upregulation [57].